These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 1619742

  • 21. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep 05; 46(RR-15):1-10. PubMed ID: 9332982
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.
    Selwyn PA, Budner NS, Wasserman WC, Arno PS.
    Public Health Rep; 1993 Sep 05; 108(4):492-500. PubMed ID: 8393579
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G.
    Int J Tuberc Lung Dis; 1998 Apr 05; 2(4):317-23. PubMed ID: 9559403
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K, Alaei A, Mansouri D.
    East Mediterr Health J; 2002 Nov 05; 8(6):754-7. PubMed ID: 15568452
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
    Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR.
    J Infect Dis; 1999 May 05; 179(5):1297-300. PubMed ID: 10191241
    [Abstract] [Full Text] [Related]

  • 36. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
    Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat HJ, Kilmarx PH, Castro KG, Wells CD.
    Lancet; 2011 May 07; 377(9777):1588-98. PubMed ID: 21492926
    [Abstract] [Full Text] [Related]

  • 37. Anergy tests draw strong reaction from experts.
    AIDS Alert; 1995 Apr 07; 10(4):47-9. PubMed ID: 11362246
    [Abstract] [Full Text] [Related]

  • 38. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA.
    AIDS; 1995 Mar 07; 9(3):267-73. PubMed ID: 7755915
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.